Literature DB >> 8786056

Epidemiology of hepatitis B virus infection in India.

B N Tandon1, S K Acharya, A Tandon.   

Abstract

The average estimated carrier rate of hepatitis B virus (HBV) in India is 4%, with a total pool of approximately 36 million carriers. Wide variations in social, economic, and health factors in different regions may explain variations in carrier rates from one part of the country to another. Professional blood donors constitute the major high risk group for HBV infection in India, with a hepatitis B surface antigen positivity rate of 14%. Blood transfusions represent the most important route of HBV transmission among adults. However, most of India's carrier pool is established in early childhood, predominantly by horizontal spread due to crowded living conditions and poor hygiene. Acute and subacute liver failure are common complications of viral hepatitis in India and HBV is reckoned to be the aetiological agent in 42% and 45% of adult cases, respectively. HBV is reported to be responsible for 70% of cases of chronic hepatitis and 80% of cases of cirrhosis of the liver. About 60% of patients with hepatocellular carcinoma are HBV marker positive. Small numbers of patients have been reported to be infected with the pre-core mutant virus but none with the S mutant. Coinfection with hepatitis C virus or hepatitis delta virus is comparatively uncommon. In conclusion, hepatitis B is a major public health problem in India and will continue to be until appropriate nationwide vaccination programmes and other control measures are established.

Entities:  

Mesh:

Year:  1996        PMID: 8786056      PMCID: PMC1398036          DOI: 10.1136/gut.38.suppl_2.s56

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India.

Authors:  A Singhvi; R B Pulimood; T J John; P G Babu; B U Samuel; T Padankatti; R H Carman
Journal:  J Trop Med Hyg       Date:  1990-06

Review 2.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

3.  Prevalence & subtypes of hepatitis B surface antigen in the tribal population of Arunachal Pradesh, India.

Authors:  S R Prasad; F M Rodrigues; S P Dhorje; C L Ramamoorthy
Journal:  Indian J Med Res       Date:  1983-09       Impact factor: 2.375

4.  Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver.

Authors:  N C Nayak; A Dhar; R Sachdeva; A Mittal; H N Seth; D Sudarsanam; B Reddy; U L Wagholikar; C R Reddy
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

5.  Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine.

Authors:  F E André
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

6.  Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India.

Authors:  B N Tandon; B M Gandhi; Y K Joshi
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

7.  Subacute hepatic failure; is it a distinct entity?

Authors:  B N Tandon; Y K Joshi; L Krishnamurthy; H D Tandon
Journal:  J Clin Gastroenterol       Date:  1982-08       Impact factor: 3.062

8.  Dynamics and impact of perinatal transmission of hepatitis B virus in North India.

Authors:  N C Nayak; S K Panda; A J Zuckerman; M K Bhan; D K Guha
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

9.  Prevalence of hepatitis B virus infection in healthy persons in North India.

Authors:  M Irshad; Y K Joshi; S K Acharya; B N Tandon
Journal:  Natl Med J India       Date:  1994 Sep-Oct       Impact factor: 0.537

Review 10.  Prevention of hepatitis B infection: the appropriate strategy for India.

Authors:  R Aggarwal; S R Naik
Journal:  Natl Med J India       Date:  1994 Sep-Oct       Impact factor: 0.537

View more
  27 in total

1.  Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission.

Authors:  Manisha Dwivedi; Sri Prakash Misra; Vatsala Misra; Arvind Pandey; Sanjay Pant; Rita Singh; Manju Verma
Journal:  Indian J Gastroenterol       Date:  2011-04-16

2.  Adolescent vaccines: Need special focus in India.

Authors:  Ramesh Verma; Pardeep Khanna; Suraj Chawla
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Hepatitis B & C among farmers - a seroprevalence study.

Authors:  Ravinder Garg; Shaminder Kaur; Rakesh Aseri; Simmi Aggarwal; Jatinder Pal Singh; Simarpreet Mann; Sumit Kumar; Sarabjot Kaur
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  Prevalence of HBV and HCV in blood donors in Kanpur during the period 1997 through 2005.

Authors:  Riddhi Jaiswal; Lubna Khan; Renu Jain; Asha Agarwal; S N Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

Review 5.  Role of surveillance in prevention of hepatocellular carcinoma.

Authors:  Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-05-25

6.  Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection.

Authors:  Kumar K Singh; Subrat K Panda; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

7.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

8.  Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.

Authors:  Rajesh Panigrahi; Avik Biswas; Sibnarayan Datta; Arup Banerjee; Partha K Chandra; Pradip K Mahapatra; Bharat Patnaik; Sekhar Chakrabarti; Runu Chakravarty
Journal:  Virol J       Date:  2010-08-27       Impact factor: 4.099

9.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

Authors:  Shanmugam Saravanan; Vijayakumar Velu; Nagalingeswaran Kumarasamy; Subhadra Nandakumar; Kailapuri Gangatharan Murugavel; Pachamuthu Balakrishnan; Solomon Suniti; Sadras Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 10.  Telbivudine: a new treatment for chronic hepatitis B.

Authors:  Deepak N Amarapurkar
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.